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Background. The present study aimed to analyze the effects of physical training on an antioxidant canonical pathway and
metalloproteinases activity in diaphragm muscle in a model of cigarette smoke-induced chronic obstructive pulmonary disease
(COPD).Methods. Malemice were randomized into control, smoke, exercise, and exercise + smoke groups, which weremaintained
in trial period of 24 weeks. Gene expression of kelch-like ECH-associated protein 1; nuclear factor erythroid-2 like 2; and heme-
oxygenase1 by polymerase chain reaction was performed. Metalloproteinases 2 and 9 activities were analyzed by zymography.
Exercise capacitywas evaluated by treadmill exercise test before and after the protocol.Results. Aerobic training inhibited diaphragm
muscle wasting induced by cigarette smoke exposure. This inhibition was associated with improved aerobic capacity in those
animals that were submitted to 24 weeks of aerobic training, when compared to the control and smoke groups, which were not
submitted to training. The aerobic training also downregulated the increase of matrix metalloproteinases (MMP-2 and MMP-9)
and upregulated antioxidant genes, such as nuclear factor erythroid-2 like 2 (NRF2) and heme-oxygenase1 (HMOX1), in exercise
+ smoke group compared to smoke group. Conclusions. Treadmill aerobic training protects diaphragmmuscle wasting induced by
cigarette smoke exposure involving upregulation of antioxidant genes and downregulation of matrix metalloproteinases.
1. Introduction
Chronic obstructive pulmonary disease (COPD) is associated
with respiratory and peripheral muscle dysfunction. REDOX
imbalance induced by cigarette smoke (CS) exposure dam-
ages lipids, proteins, and nucleic acids and is involved in
diaphragm remodeling and muscle atrophy in COPD [1, 2].
However, little is known regarding the key role of extracellular
matrix (ECM) remodeling associated with oxidative stress on
respiratory muscles weakness in COPD during chronic CS
exposure. Metalloproteinases (MMPs), MMP-2, and MMP-
9 are proteolytic enzymes that play an essential role in ECM
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remodeling of skeletalmuscle [3–6]. Studies have showed that
MMPs also are involved in inflammation and development
of interstitial fibrosis of many organs [7–9]. In addition,
Yao et al. 2013 [10] have showed in mice and humans a
contribution of the imbalance between tissue inhibitors of
MMPs (TIMPs) and MMPs, notably between TIMP-1 and
MMP-9 [10]. Increased gene expression and activity ofMMP-
9 and MMP-2 in diaphragm muscle were also observed,
which can contribute to the skeletal muscle myopathy during
heart failure [11, 12].
It is well described that REDOX imbalance has a positive
correlation with upregulation of MMPs [13, 14]. Rajagopalan
et al. (l996) [14] noticed that increased levels of free radicals,
both reactive oxygen species (ROS) and reactive nitrogen
species (RNS), induced activation of MMP-2 and MMP-
9 in cultured smooth muscle cells. Kameda et al. (2003)
[13] also showed increased activity of MMP-2 and MMP-
9 and oxidative stress, resulting in ventricular remodeling
(enlargement), followed by increased rate of morbidity and
mortality of patients with coronary artery disease. Although
the regulation of these enzymes is associated with oxidative
stress in heart and lungs, their expression in the diaphragm
after chronic CS exposure remains unknown.
Nuclear transcriptional factor (erythroid-derived 2)-like
2 (NRF2) pathway constitutes a regulatory pathway against
nocive effects caused by oxidative stress through antioxidant
genes upregulation [15, 16]. Some studies have suggested
that, in physiological conditions, NRF2 is maintained in
the cytosol by a cluster of proteins, including its cytoso-
lic inhibitor, kelch-like ECH-associated protein 1 (KEAP1).
However, during stressful responses, redox imbalances, and
cancer evolution, it dissociates from KEAP1 and translocates
to the nucleus to regulate the transcription of antioxidant
genes [17], such as heme-oxygenase1 (HMOX1).Thismolecu-
lar mechanism has been observed in liver, lungs, and kidneys
through KEAP1 knockdown mice approach. However in the
skeletal muscle this pathway remains unclear [18]. Further-
more, a recent study has showed that NRF2 also could be
associated with regulation of MMPs. In this report higher
levels of MMP-9 activity in (−/−) NRF2 knockdown mice
were noticedwhen compared toNRF2 (+/+)mice after Spinal
Cord Injury (SCI), suggesting that NRF2 plays a protective
role in spinal cord, possibly by limiting the inflammatory
response that occur after SCI via MMP-9 modulation [19].
Despite the fact that some studies have reported the critical
role ofNRF2 in themodulation of inflammation [19, 20], little
is known about the crosstalk between MMPs and NRF2 in
ECM remodeling, especially in diaphragm muscle exposed
to CS [21, 22]. Aerobic training in COPD patients alleviates
symptoms, improves quality of life, and decreases exacerba-
tion episodes and the risk of mortality in COPD. Moreover,
there are evidences that aerobic training has an essential role
in the prevention and progression of pulmonary disease due
to cigarette smoking [23]. Interestingly, some reports showed
that aerobic training also decreases the incidence of a wide
range of ROS-associated diseases, including heart disease,
type II diabetes, cigarette smoke-induced pulmonary disease,
and certain types of cancers through the improvement of
antioxidant defenses [23, 24]. Although the literature presents
a consensus about the essential role of NRF2 pathway for the
protection against oxidative stress, there is no evidence about
activity of NRF2 andHMOX1 pathways after aerobic training
in mice exposed to cigarette smoke. In addition, there is
limited information on how physical training can affect ECM
turnover in respiratory muscles as well as oxidative and
antioxidative response to protect skeletal muscle against CS.
Therefore, the goal of this study was to analyze the effects
of physical training in the NRF2-HMOX1, an antioxidant
canonical pathway, and the MMP-2 and MMP-9 activities in
diaphragm muscle after CS exposure. We hypothesized that
chronic CS exposure would increase the MMPs activity and
decrease the expression of antioxidant enzymes in diaphragm
muscle, while aerobic conditioning would result in an oppo-
site and positive effect.
2. Material and Methods
2.1. Animals and Experimental Design. Male C57BL/6 mice
(6–8 weeks; 20.10 ± 4.73 g) were randomized into four groups
of 8 animals per group: (1) control; (2) smoke (exposed
to cigarette smoke); (3) exercise (submitted to treadmill
training); and (4) exercise + smoke (submitted to treadmill
training and exposed to cigarette smoke). The animals were
housed in plastic cages under controlled environmental
conditions (12-hour light/dark cycle) with free access to water
and standard chow (Socil, Sa˜o Paulo). The protocol of the
present study was approved by the ethical committee of
Faculdade de Medicina da Univesidade de Sa˜o Paulo (Sa˜o
Paulo-Brazil) and was developed in compliance with the
“Guide for care and use of laboratory animals” [25].
2.2. Cigarette Smoke Exposure Protocol. In order to induces
COPD, animals were subjected to 12 commercially filtered
cigarettes per day (0,8mg of nicotine, 10mg of tar, and 10mg
of CO per cigarette), corresponding to a total particulate
matter concentration of 354.8 ± 50.3mg⋅m−3⋅day−1. The CS
exposure was performed placing the animals into a box
(inhalation chamber) maintaining controlled CO levels (250
to 350 ppm) for 30min a day−1, 5 days a week−1 for 24 weeks.
Control animals were exposed to the same protocol, but using
roomair [23]. In addition, carboxyhemoglobin concentration
in smoke-exposed animals was kept at 10% (±1,3%).
2.3. Treadmill Aerobic Training and Test. After an adaptation
to aerobic treadmill training (3 days, 15min a day−1, 25%
inclination and 0.2 km/h−1), a physical test was performed to
evaluate the maximal exercise capacity (100%), as previously
described [23]. Animals were trained at 50% of maximal
exercise capacity for 60min/day, 5 days per week for 24
weeks, and CS exposure was always performed after 1 hour
of physical training. Aerobic training started on the same day
as the beginning of cigarette smoke exposure and continued
until the end of the experimental protocol [23].
2.4. Zymography. Diaphragm muscle was chosen because it
is the most important respiratory muscle during quiet and
effort breathings.Mice were weighed and diaphragmmuscles
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Table 1: Final body weight and diaphragm muscle weight of experimental groups.
Control Smoke Exercise Exercise + smoke
Initial body (g) 38.79 ± 3.33 38.56 ± 5.56 39.51 ± 6.39 39.53 ± 4.14
Final body (g) 33.59 ± 2.59§ 50.16 ± 3.09a§ 33.34 ± 2.70§ 46.44 ± 4.36a§
Gain (%) 13.41 30.08§ 15.62 17.48§
Diaphragm weight (mg) 98.8 ± 23.2 60.1 ± 13.6a 89.5 ± 39.4 109.9 ± 19.6b
Normal diaphragmmuscle (control); exercise in the treadmill (exercise); group exercise in the treadmill associated to chronic cigarette smoke exposure (exercise
+ smoke); group submitted to chronic cigarette smoke exposure (smoke). Data are expressed as mean ± standard deviation. a = 𝑝 < 0.05: compared to control
group; b = 𝑝 < 0.05: compared to smoke group; §𝑝 < 0.05: intragroup comparison.
were carefully removed, weighed, and frozen for zymography
evaluation. Tissue extraction and zymographic analysis were
performed according to current methodology [26]. Briefly,
equal amounts of total protein (30 𝜇g/lane), consisting of
a pool of five animals per group (6 𝜇g per animal), were
subjected to electrophoresis in triplicate. Zymography gels
consisted of 10% polyacrylamide impregnated with gelatin
at a final concentration of 100mg/ml H2O in the presence
of sodium dodecyl sulfate (SDS), under nonreducing con-
ditions. After 2 hours of electrophoresis (100V), the gels
were washed twice for 20 minutes in a 2.5% Triton X-100
solution and incubated at 37∘C for 20 h in a substrate buffer
(50mM Tris-HCl, pH 8.5, 5mM CaCl2, and 0.02% NaN3).
The gels were stained with Coomassie Brilliant Blue R-250
for 30 minutes and stained in methanol and acetic acid for 20
minutes. Gelatin-degrading enzymes were visualized as clear
white bands against a blue background, indicating proteolysis
of the substrate protein. The samples were also assayed in
presence of 15mM EDTA that inhibited MMP activity. The
molecular mass of gelatinolytic activities was determined
by comparison to reference protein molecular mass marker,
PageRulerTM Prestained Protein Ladder (Fermentas Life
Sciences, Burlington, ON). Activity bands were identified
following previously description, according to their molec-
ular weights (92 kDa: pro-MMP-9; 81 kDa: active-MMP-9;
72 kDa: pro-MMP-2; 66 kDa: intermediary-MMP-2; 62 kDa:
active-MMP-2) [26]. The bands found in all groups were
72–62 kDa, suggesting the activation of MMP-2 as proposed
by [27]. Active bands were emphasized as described by [28].
Data is expressed as concentration ofMMP-2 (i.e., the totality
of integrated optical density for the MMP-2 proenzyme,
intermediate, and active forms) and MMP-2 active form.
Densitometry quantitative analysis of the protein bands in the
zymography was performed using GeneTools v3.06 software
(Syngene, Cambridge, UK).
2.5. Gene Expression by Real-Time PCR. Total RNA was
isolated from diaphragm muscle using TRI-Reagent (Sigma,
St. Louis,MO,USA). RNA quantity and quality were assessed
using RNA Nano 6000 kit on a 2100 Bioanalyzer capillary
electrophoresis system (Agilent, Santa Clara, CA, USA).
Reverse transcription was carried out using High-Capacity
cDNA Reverse Transcription Kit with RNase Inhibitor
(Applied Biosystems). Gene expression was evaluated by
quantitative real-time PCR. Two microliters of each reverse
transcription product were amplified in 20 L of 1X reaction
buffer (TaqManUniversal PCRMasterMix, Applied Biosys-
tems) using appropriate TaqMan gene expression assays
in a Step One Plus Thermocycler (Applied Biosystems)
for the following genes: NRF2 (Mm00477784 m1); KEAP1
(Mm00497268 m1); andHMOX1 (Mm00516005 m1). Abun-
dance of mRNA for different genes in the diaphragm muscle
was calculated with the use of 2−ΔΔCt method and Beta-actin
was used as the reference gene [29].
2.6. Statistical Analysis. Kolmogorov–Smirnov and Levene
tests were used to analyze the normality and homogeneity of
variance. Two-wayANOVA(factors: smoke and exercise)was
used to identify differences among groups. When differences
were observed, Tukey test was performed. Differences were
considered significant when 𝑝 < 0.05. All data were analyzed
using the Statistica 7.0 software package (StatSoft Inc., Tulsa,
OK, USA).
3. Results
3.1. Aerobic Exercise Capacity. After 24 weeks of aerobic
training, the exercise time on treadmill and the maximal
speed were significantly greater in those groups that trained
endurance exercise, when compared to the groups that were
not trained. In Figure 1, aerobic capacity improvement is
noticed in the exercise group, compared to control one (𝑝 <
0.05; Figure 1), as well as in exercise + smoke group compared
to smoke group (𝑝 < 0.05; Figure 1).
3.2. Body and Muscle Weight
3.2.1. Body Weight. Curiously, 24 weeks of cigarette smoke
exposure caused an increase in body weight in both groups
(smoke and smoke + exercise groups) that receive smoke
tobacco when comparing their initial and final weights and
when comparing them to the control group (𝑝 < 0.05).
Moreover, body weight decrease was observed in control and
exercise group, when comparing their initial and final weights
(𝑝 < 0.05; Table 1).
3.2.2. Diaphragm Muscle Weight. The chronic cigarette
smoke exposure reduced significantly the weight of the
diaphragm muscle compared to control (𝑝 < 0.05; Table 1).
However, it was also noticed that aerobic exercise prevented
muscle weight loss in exercise + smoke group, when com-
pared to the smoke group that was not trained. In the control
















































Figure 1: Results of the tests performed on the treadmill to evaluate
the intensity of aerobic conditioning of the studied mice. Tests were
performed before the beginning of the exposure to cigarette smoke
(time 0) and 24 weeks of the protocol. (a) Time that the mice could
exercise in the treadmill; (b) maximal speed reached by each mouse
among the four experimental groups. Data are presented as means
and standard deviation. A = 𝑝 < 0.05: compared to control group. B
= 𝑝 < 0.05: compared to smoke group.
and exercise groups no changes were observed after 24 weeks
of training.
3.3. Gene Expression by qPCR
3.3.1. NRF2. Aerobic training, in exercise group, upregulated
NFR2 gene expression in approximately four times, when
compared to control and smoke groups (𝑝 < 0.05, resp.).
There was alsoNRF2 gene expression increase in the exercise
+ smoke group, compared to the smoke and control group
(𝑝 < 0.05, resp.). Different from the expected, no differences
in NRF2 gene expression between smoke and control groups
were observed. However, exercise + smoke group presented
increased NRF2 gene expression, when compared to exercise
group (𝑝 < 0.05, resp.) (Figure 2(a)).
3.3.2. HMOX. In relation to HMOX1 gene expression that is
transcriptionally regulated byNRF2, no difference was found
between exercise and control group. On the other hand,
HMOX1 gene expression decrease was found in smoke group,
when compared to control (𝑝 < 0.05, resp.). Despite HMOX1
downregulation in smoke group, aerobic training promoted
increases in HMOX1 gene expression in exercise + smoke
group, in comparison to control, smoke, and exercise groups,
according to what could be seen in Figure 2(b). (𝑝 < 0.05,
resp.)
3.3.3. KEAP1. Similar regulation between NRF2 and KEAP1
was noticed in qPCR. KEAP1 (NFR2 inhibitor) gene expres-
sion increase was observed, in exercise group, when com-
pared to control and smoke group (𝑝 < 0.05, resp.). Similar
datawas observed in exercise + smoke group,when compared
to other groups (control, exercise, and exercise + smoke)
(𝑝 < 0.05, resp.). An increase of KEAP1 gene expression
in the exercise + smoke group compared to exercise group
is also observed (𝑝 < 0.05, resp.). These results suggest a
possible counter-regulatory mechanism between KEAP1 and
NRF2 (Figure 2(c)).
3.4. MMP-2 and MMP-9 Activity of Diaphragm Muscle. The
total MMP-2 activity and MMP-9 activity were elevated only
in smoke group, compared to all experimental groups (con-
trol, exercise, and exercise + smoke) (𝑝 < 0.05; Figure 3(a)).
No differences were found among exercise, exercise + smoke,
and control groups (𝑝 < 0.05; Figure 3(b)).
3.5. Discussion. Our results indicate the importance of aero-
bic training over ECMremodeling throughMMPs and oxida-
tive stress in diaphragm muscle mass regulation. Aerobic
training maintained MMP-2 and MMP-9 activities in basal
levels and increased NRF2 and HMOX1 expression (antiox-
idant genes), which could be associated with protective
effects of physical training during chronic CS exposure.These
results are of particular interest since, in humans, COPD is
the most common respiratory disease, with progressive and
irreversible decline of lung function, in which the diaphragm
dysfunction presents an important role.We showed thatmice
exposure to CS for 24 weeks decreased diaphragm muscle
weight ∼40% compared to the control group, suggesting that
CS activated muscle proteolysis. We believe that muscle pro-
teolysis observed in diaphragm muscle could be associated
with inflammatory reaction and excessive ROS production.
This hypothesis could be reinforced, since a decrease in
HMOX1 gene expression andMMP-9 (inflammatorymarker)
activity increase were observed in smoke group, compared
to the control group. On the other hand, the results also










































































Figure 2: The messenger RNA (mRNA) levels of nuclear factor
erythroid-2 like 2 (NRF2), heme-oxygenase1 (HMOX1), and kelch-
like ECH-associated protein 1 (KEAP1) of diaphragm muscle. Data
are expressed asmean± standard deviation. A =𝑝 < 0.05: compared
to control group; B = 𝑝 < 0.05: compared to smoke group; C =
𝑝 < 0.05: compared to exercise group.
showed that aerobic training is a potential intervention to
prevent the imbalance betweenMMPs and antioxidant genes,
caused by tobacco, in diaphragm muscle. Therefore, these
results suggest that aerobic training has controlled muscle
mass wasting through the regulation of antioxidant pathways.
Some studies have shown a regulatory mechanism
between HMOX1 and transcriptional factor NRF2. Clinical
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Figure 3: Representative gelatinolysis activity and gelatin zymogra-
phies in diafragham muscle of mice chronic cigarette smoke expo-
sure. (a) Densitometry metalloproteinase-2 (MMP-2) gelatinolysis
activity groups; (b) densitometry metalloproteinase-9 (MMP-9)
gelatinolysis activity groups; (c) MMP-2 gelatin zymographies; (d)
MMP-9 gelatin zymographies. A = 𝑝 < 0.05: compared to control
group.
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and experimental studies have shown that NRF2 downreg-
ulation in the lungs of COPD patients and mice caused
more susceptible development to emphysema after exposure
to cigarette smoke [30–32]. Interestingly, in the present
study, increase in NRF2 gene expression was observed in the
exercise + smoke group, compared to the smoke group. It
is possible to suggest that aerobic training plays a key role
mediating the upregulation of the antioxidant system, in an
attempt to protect muscle cells against ROS, in special, in
diaphragm muscle, which was analyzed here. Curiously, we
did not demonstrate difference in HMOX1 gene expression
between control and exercise group.Therefore, other mecha-
nismsmight be involved in the regulation betweenNRF2 and
HMOX1 in physiological conditions [30].
It is well described that KEAP1 is a regulatory bind
protein of NRF2 in the cytosol facilitating its degradation
by 26S proteasome [30, 31, 33, 34] Therefore, we might
expect that KEAP1 would be downregulated compared to
NRF2, in both exercise and exercise + smoke. Different
from what we expected, an increase of KEAP1 in those
groups was observed. The increase of KEAP1 could be a cell
mechanism to balance an excessive increase of NRF2, which
is involved in the transcription of antioxidant target gene
[30].However, an increase ofKEAP1 gene expression between
smoke and control group was not observed. We believe that
the expression of KEAP1 at basal levels might be enough
to inhibit NRF2 migration into nucleus and consequently
inducing antioxidants transcription, but further studies are
necessary to better understand the relation between KEAP1-
NRF2 pathway in exercise and CS models.
The role of MMPs on ECM remodeling related to
diaphragm muscle mass wasting has been poorly inves-
tigated. Our results support that CS exposure increases
MMP-2 and MMP-9 activities, which might be associated
with diaphragm mass muscle wasting in mice, whereas
animals that were exposed to CS and submitted to exer-
cise maintained MMPs activities similar to control group.
Although the present study would not provide a direct
regulatory mechanism between MMPs (MMP-2 and MMP-
9) and antioxidant pathway (NRF2-HMOX1), this is the first
report demonstrating the protective mechanisms induced
by exercise on diaphragm muscle mass decrease following
CS exposure. The data reported in the present study could
be reinforced by study published by Mao et al. in 2010
[19] that proved that NRF2 has a critical role in MMP-9
upregulation of mice which were knockdown to NRF2. In
addition, Hindi et al. 2013 [5] showed in dystrophic muscle
of mdx mice that MMP-9 inhibition improves proliferation
and engraftment of myogenic cells. According to this study,
the role of MMP-9 in DucheneMuscular Dystrophy could be
mediated by activation of proinflammatory cytokines leading
to increased inflammatory response and degradation of ECM
components [5, 35]. Future investigations will be necessary to
prove the relation amongNRF2,MMPs, andmuscle remodel-
ing.
It is well known that the activation of MMP-2 and MMP-
9 in skeletal muscle occurs despite exercise intensity and
varies according to the type of muscle evaluated [26, 36].
Durigan and colleagues (2009) [26] observed that treadmill
training at low or moderate intensities (resp., 50% or 75%
of maximal speed reached in the test) during 60 minutes a
day, 5 days a week for 12 weeks, did not alter MMPs activity
of diaphragm muscle. These data are in agreement with
the data presented here, suggesting that a training protocol
at moderate intensity (50% of maximal speed) maintained
ECM remodeling in normal condition beneficiating the
maintenance of diaphragmmuscle remodeling in the exercise
+ smoke group.
In fact, training protocol at moderate intensity of exercise
attenuated the harmful effects of CS exposure, regarding both
MMP-9 and MMP-2 activities, in diaphragm muscle mass
decrease. These results could be associated with the reduc-
tion of diaphragm muscle myopathy in CS, as previously
described by Carvalho et al. (2006) [11] during heart failure.
It was reported that mouse model of CS induces parenchyma
mechanical dysfunction and lung remodeling, leading to
impaired respiratorymechanic [23]. Probably, thesemechan-
ical changes could increase diaphragmmuscle workload dur-
ing training, since an increase has been observed in MMP-2
and MMP-9 activities only in CS animals. However, exercise
training tends to soften the enhancement of MMPs activities,
inherent to CS exposure. It is interesting to notice that, dur-
ing physical exercise, abnormal dynamic in the ventilatory
pattern can be observed in flow-limited patients, resulting
in functional inspiratory muscle weakness by maximally
shortening the muscle fibers in the diaphragm [37, 38]. The
combination of excessive mechanical loading and increased
velocity of shortening of the inspiratory muscles can also
predispose them to fatigue [39]. As we did not observe
diaphragm ECM remodeling in a mice model of COPD in
trained group, it is possible to suggest that training did not
lead to abnormal dynamic ventilatory and disadvantages of
diaphragm, regarding force generation.
4. Conclusion
Aerobic training protects diaphragmmuscle wasting induced
by chronic CS exposure involving upregulation of antioxidant
pathway, NRF-2/HMOX, and downregulation of the matrix
metalloproteinases MMP-2 and MMP-9.
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